Spreadsheet Data
Audit the saved peer set and the method inputs behind the blended fair value.
Review the saved peer set across price, scale, operating metrics, and raw valuation multiples.
| Peer | Price | Market Cap | Enterprise Value | Revenue | EBITDA | Net Income |
|---|
| P/E |
|---|
| P/S |
|---|
| EV/EBITDA |
|---|
AB ABT ABBOTT LABORATORIES FY ended Jan 31, 2026 | $108.93 | $189.74B | $203.69B | $44.33B | $12.22B | $6.52B | 29.28x | 4.28x | 15.96x |
MD MDT Medtronic plc FY ended Jun 12, 2026 | $92.04 | $117.82B | $134.91B | $36.36B | $9.78B | $4.80B | 24.68x | 3.24x | 12.79x |
BD BDX BECTON DICKINSON & CO FY ended Oct 31, 2025 | $187.12 | $50.97B | $72.12B | $21.84B | $4.81B | $1.68B | 32.15x | 2.33x | 13.16x |
See which peer averages feed the weighted fair value and which methods are excluded.
| Method | Type | Avg. Multiple | Coverage | Implied Equity Value | Fair Value / Share | Status |
|---|---|---|---|---|---|---|
EV / EBITDA EVActive | Enterprise Multiple | 12.31x | 3/3 | $14.14B | $37.48 | Included in the active peer mix. |
Price / Sales PSActive | Equity Multiple | 3.28x | 3/3 | $15.31B | $40.58 | Included in the active peer mix. |
Price / Earnings PEActive | Equity Multiple | 28.70x | 3/3 | $24.00B | $63.61 | Included in the active peer mix. |
Open the saved peer table used to audit the fair value view.
| Peer | Price | Market Cap | Enterprise Value | Revenue | EBITDA | Net Income | P/E | P/S | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
AB ABT ABBOTT LABORATORIES FY ended Jan 31, 2026 | $108.93 | $189.74B | $203.69B | $44.33B | $12.22B | $6.52B | 29.28x | 4.28x | 15.96x |
MD MDT Medtronic plc FY ended Jun 12, 2026 | $92.04 | $117.82B | $134.91B | $36.36B | $9.78B | $4.80B | 24.68x | 3.24x | 12.79x |
BD BDX BECTON DICKINSON & CO FY ended Oct 31, 2025 | $187.12 | $50.97B | $72.12B | $21.84B | $4.81B | $1.68B | 32.15x | 2.33x | 13.16x |
Open the peer-average inputs behind the weighted result.
| Method | Type | Avg. Multiple | Coverage | Implied Equity Value | Fair Value / Share | Status |
|---|---|---|---|---|---|---|
EV / EBITDA EVActive | Enterprise Multiple | 12.31x | 3/3 | $14.14B | $37.48 | Included in the active peer mix. |
Price / Sales PSActive | Equity Multiple | 3.28x | 3/3 | $15.31B | $40.58 | Included in the active peer mix. |
Price / Earnings PEActive | Equity Multiple | 28.70x | 3/3 | $24.00B | $63.61 | Included in the active peer mix. |